ADTX logo

Aditxt (ADTX)

Profile

Full Name

Aditxt, Inc.

Ticker Symbol

ADTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 30, 2020

Indexes

Not included

Website

http://www.aditxt.com

Employees

26

Key Details

Price

$2.50(+13.64%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$134.00K(-79.23% YoY)

Annual EPS

-$311.18(+99.88% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.50
ADTX price is $2.50

30-Day Relative Volume

0.12
ADTX 30-day relative volume is 0.12

Price Performance

Price Most recent change

+13.64%
ADTX price was up +13.64% on Apr 17, 2025

Price YTD change

-94.74%
ADTX price is down -94.74% since January 1st

Price 1-year change

-99.99%
ADTX price is down -99.99% year-on-year

Price 3-year change

-100%
ADTX price is down -100% over the past 3 years

Price Range

Price All-time high

$191600000.00
ADTX price is currently -100.00% below its historical high of $191600000.00

Price 3-year low

$2.04
ADTX price is currently +22.55% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.02M
ADTX market capitalization is $3.02 million

Market cap 3-year change

+100%
ADTX market capitalization is up +100% over the past 3 years

Market cap All-time high

$11.02M
ADTX market capitalization is currently -72.60% below its historical high of $11.02 million

Market cap sector rank

8.56%
ADTX market capitalization is higher than 8.56% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+603850%
ADTX shares outstanding is up +603850% year-on-year

Shares Outstanding 3-Year Change

+100%
ADTX shares outstanding is up +100% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.09
ADTX beta is -0.09

200-day SMA

$3138.34
ADTX price is currently -99.92% below its 200-day simple moving average

50-day SMA

$12.15
ADTX price is currently -79.42% below its 50-day simple moving average

RSI

30.37
ADTX 14-day relative strength index is 30.37

Volume

0.12
ADTX 30-day relative volume is 0.12

ATR

$1.18
ADTX average true range is $1.18

10-day Historical Volatility

152.79%
ADTX 10-day historical volatility is 152.79%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$134.00K
ADTX annual revenue is $134.00 thousand

Revenue Analysts estimate

$1.20M
ADTX annual revenue is currently -88.83% lower than the consensus analysts' forecast

Revenue 1-year change

-79.23%
ADTX annual revenue is down -79.23% year-on-year

Revenue Sector rank

5.72%
ADTX annual revenue is higher than 5.72% of companies in Healthcare sector

EPS

EPS

-$311.18
ADTX annual earnings per share is -$311.18

EPS Analysts estimate

-
ADTX annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+99.88%
ADTX annual earnings per share is up +99.88% year-on-year

EPS Sector rank

0.99%
ADTX annual earnings per share is higher than 0.99% of companies in Healthcare sector

Profit

Gross profit

-$493.50K
ADTX annual gross profit is -$493.50 thousand

Gross margin

-368.32%
ADTX annual gross profit margin is -368.32%

Operating profit

-$27.86M
ADTX annual operating income is -$27.86 million

Operating margin

-20.80K%
ADTX annual operating profit margin is -20.80 thousand%

Net income

-$34.45M
ADTX annual net profit is -$34.45 million

Net margin

-25.71K%
ADTX annual net profit margin is -25.71 thousand%

Expenses

Total expenses

$28.00M
ADTX annual total expenses is $28.00 million

Operating expenses

$27.37M
ADTX annual total operating expenses is $27.37 million

Cost of goods sold

$627.50K
ADTX annual cost of goods sold is $627.50 thousand

Selling, general & administrative expenses

$16.48M
ADTX annual SGA is $16.48 million

Depreciation and amortization

$617.30K
ADTX annual depreciation & amortization is $617.30 thousand

Interest expense

$7.36M
ADTX annual interest expense is $7.36 million

Income tax

$0.00
ADTX annual income tax is $0.00

EBIT & EBITDA

EBIT

-$27.66M
ADTX annual earnings before interest & taxes is -$27.66 million

EBITDA

-$27.04M
ADTX annual EBITDA is -$27.04 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$32.14M
ADTX annual total assets is $32.14 million

Non current assets

$30.14M
ADTX annual long term assets is $30.14 million

Current assets

$2.00M
ADTX annual total current assets is $2.00 million

Cash and cash equivalents

$833.00K
ADTX annual cash & cash equivalents is $833.00 thousand

Accounts receivable

$43.40K
ADTX annual accounts receivable is $43.40 thousand

Inventory

$11.20K
ADTX annual inventory is $11.20 thousand

Liabilities

Total liabilities

$23.86M
ADTX annual total liabilities is $23.86 million

Long term liabilities

$450.90K
ADTX annual total long term liabilities is $450.90 thousand

Current liabilities

$23.41M
ADTX annual total current liabilities is $23.41 million

Accounts payable

$10.19M
ADTX annual accounts payable is $10.19 million

Debt

Total debt

$6.92M
ADTX annual total debt is $6.92 million

Total debt 1-year change

-62.01%
ADTX annual total debt is down -62.01% year-on-year

Long term debt

$436.40K
ADTX annual long term debt is $436.40 thousand

Short term debt

$6.48M
ADTX annual short term debt is $6.48 million

Equity & Capital

Shareholders equity

$8.87M
ADTX annual stockholders equity is $8.87 million

Book value

$496.50K
ADTX annual book value is $496.50 thousand

Retained earnings

-$168.09M
ADTX annual retained earnings is -$168.09 million

Working capital

-$21.41M
ADTX annual working capital is -$21.41 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$16.76M
ADTX annual cash flow from operations is -$16.76 million

Cash from operations 1-year change

+12.71%
ADTX annual cash flow from operations is up +12.71% year-on-year

Cash from investing

-$5.00M
ADTX annual cash flow from investing activities is -$5.00 million

Cash from investing 1-year change

-34622.22%
ADTX annual cash flow from investing activities is down -34622.22% year-on-year

Cash from financing

$22.50M
ADTX annual cash flow from financing activities is $22.50 million

Cash from financing 1-year change

+35.97%
ADTX annual cash flow from financing activities is up +35.97% year-on-year

CAPEX

CAPEX

-
ADTX annual capital expenditures value is unknown

CAPEX 1-year change

-
ADTX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$16.76M
ADTX annual free cash flow is -$16.76 million

Free cash flow 1-year change

+12.78%
ADTX annual free cash flow is up +12.78% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-368.32%
ADTX annual gross profit margin is -368.32%

Operating margin

-20.80K%
ADTX annual operating profit margin is -20.80 thousand%

Net margin

-25.71K%
ADTX annual net profit margin is -25.71 thousand%

ROA & ROE

ROA

-89.79%
ADTX annual return on assets is -89.79%

ROE

-283.12%
ADTX annual return on equity is -283.12%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ADTX price to earnings ratio value is unknown

PE ratio Sector rank

-
ADTX price to earnings ratio is unknown

PB Ratio

PB ratio

6.08
ADTX price to book ratio is 6.08

PB ratio Sector rank

86.48%
ADTX price to book ratio is higher than 86.48% of companies in Healthcare sector

PS Ratio

PS ratio

22.52
ADTX price to sales ratio is 22.52

PS ratio Sector rank

87.03%
ADTX price to sales ratio is higher than 87.03% of companies in Healthcare sector

Enterprise value

Enterprise value

$9.11M
ADTX enterprise value is $9.11 million

Enterprise value Sector rank

23.55%
ADTX enterprise value is higher than 23.55% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.34
ADTX EV/EBITDA is -0.34

EV/EBITDA Sector rank

55%
ADTX EV/EBITDA is higher than 55% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.09
ADTX annual current ratio is 0.09

Quick ratio

0.08
ADTX annual quick ratio is 0.08

Leverage

Debt to equity

0.65
ADTX annual debt to equity ratio is 0.65

Interest coverage ratio

-3.76
ADTX annual interest coverage ratio is -3.76

Risk & Stability

Piotroski F-Score

2
ADTX piotroski f-score is 2

Altman Z-Score

-10.88
ADTX altman z-score is -10.88

Analyst ratings

Recent major analysts updates

Sep 6, 23 HC Wainwright & Co.
Buy
Sep 16, 22 Dawson James
Neutral

Institutional Ownership

Similar stocks

LIXT logo
Lixte Biotechnology Holdings (LIXT)
OMGA logo
Omega Therapeutics (OMGA)
MTNB logo
Matinas BioPharma Holdings (MTNB)
SPRC logo
SciSparc (SPRC)
TTOO logo
T2 Biosystems (TTOO)
ICCT logo
iCoreConnect (ICCT)
TLIS logo
Talis Biomedical (TLIS)
ONVO logo
Organovo Holdings (ONVO)
GLMD logo
Galmed Pharmaceuticals (GLMD)
  • What is the ticker symbol for Aditxt?
  • Does Aditxt pay dividends?
  • What sector is Aditxt in?
  • What industry is Aditxt in?
  • What country is Aditxt based in?
  • When did Aditxt go public?
  • Is Aditxt in the S&P 500?
  • Is Aditxt in the NASDAQ 100?
  • Is Aditxt in the Dow Jones?
  • When was Aditxt's last earnings report?
  • When does Aditxt report earnings?
  • Should I buy Aditxt stock now?

What is the ticker symbol for Aditxt?

The ticker symbol for Aditxt is NASDAQ:ADTX

Does Aditxt pay dividends?

No, Aditxt does not pay dividends

What sector is Aditxt in?

Aditxt is in the Healthcare sector

What industry is Aditxt in?

Aditxt is in the Biotechnology industry

What country is Aditxt based in?

Aditxt is headquartered in United States

When did Aditxt go public?

Aditxt's initial public offering (IPO) was on June 30, 2020

Is Aditxt in the S&P 500?

No, Aditxt is not included in the S&P 500 index

Is Aditxt in the NASDAQ 100?

No, Aditxt is not included in the NASDAQ 100 index

Is Aditxt in the Dow Jones?

No, Aditxt is not included in the Dow Jones index

When was Aditxt's last earnings report?

Aditxt's most recent earnings report was on Nov 15, 2021

When does Aditxt report earnings?

The next expected earnings date for Aditxt is May 30, 2025

Should I buy Aditxt stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page